NeoGenomics, Inc. (NASDAQ:NEO) | WebDisclosure

Switch to English

9557	Sociétés
188785	Mots-clés
120541	Articles
100763	Communiqués

Accueil
Sociétés
NeoGenomics, Inc.

COMMUNIQUÉ DE PRESSE

publié le 28/12/2023 à 14:10, il y a 1 année 11 mois

NeoGenomics to Appeal Ruling
NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
COMMUNIQUÉ DE PRESSE

publié le 05/12/2023 à 14:00, il y a 2 années

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial

NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
COMMUNIQUÉ DE PRESSE

publié le 14/11/2023 à 13:00, il y a 2 années 1 mois

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
COMMUNIQUÉ DE PRESSE

publié le 06/11/2023 à 22:05, il y a 2 années 1 mois

NeoGenomics Reports Third Quarter 2023 Results
COMMUNIQUÉ DE PRESSE

publié le 24/10/2023 à 13:00, il y a 2 années 1 mois

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
COMMUNIQUÉ DE PRESSE

publié le 17/10/2023 à 15:20, il y a 2 années 2 mois

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

Les Echos

Publié le 19/12/2025 à 08:30, il y a 10 heures 24 minutes

Share capital decrease by way of treasury shares cancellation
Publié le 19/12/2025 à 08:30, il y a 10 heures 24 minutes

Réduction du capital par voie d’annulation d’actions propres
Publié le 19/12/2025 à 07:00, il y a 11 heures 54 minutes

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Publié le 19/12/2025 à 07:00, il y a 11 heures 54 minutes

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Publié le 18/12/2025 à 18:30, il y a 1 jour

Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 19/12/2025 à 18:30, il y a 24 minutes

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Publié le 19/12/2025 à 14:40, il y a 4 heures 14 minutes

Northern Superior Announces Closing of the Arrangement
Publié le 19/12/2025 à 13:30, il y a 5 heures 24 minutes

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Publié le 19/12/2025 à 13:30, il y a 5 heures 24 minutes

DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Publié le 19/12/2025 à 13:30, il y a 5 heures 24 minutes

Sterling Metals Provides Year End Update to Stakeholders

Voir tout ACCESSWIRE

EQS Group

Publié le 19/12/2025 à 18:29, il y a 24 minutes

clearvise AG commissions Triticum agri-photovoltaic project
Publié le 19/12/2025 à 18:29, il y a 25 minutes

Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 19/12/2025 à 18:27, il y a 27 minutes

Resumed Trading in the Bond
Publié le 19/12/2025 à 18:19, il y a 35 minutes

POS-Transaction in Own Shares
Publié le 19/12/2025 à 17:56, il y a 57 minutes

Affluent Medical annonce l’acquisition prochaine de Caranx Medical et Artedrone et devient Carvolix, pionnier des thérapies cardiovasculaires.